PMI’s iQOS enters FDA process, edging closer to U.S. launch
3rd April 2017 - News analysis |
Philip Morris International (PMI) has submitted its iQOS heat-not-burn system for approval by the U.S. Food and Drug Administration (FDA).
Philip Morris International (PMI) has submitted its iQOS heat-not-burn system for approval by the U.S. Food and Drug Administration (FDA).
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.